Vice Provost and Dean of Research


Showing 1,951-2,000 of 2,496 Results

  • J Kenneth Salisbury, Jr.

    J Kenneth Salisbury, Jr.

    Professor (Research) of Computer Science and of Surgery (Anatomy), Emeritus

    BioSalisbury worked on the development of the Stanford-JPL Robot Hand, the JPL Force Reflecting Hand Controller, the MIT-WAM arm, the PR-2 personal robot and the da Vinci Surgical Robot. His work with haptic interface technology led to the founding of SensAble Technology, producers of the PHANToM haptic interface and software. He also worked on developing telerobotic systems for dexterity enhancement in the operating room. His current research focuses on minimalist force controllable robots, human-machine interaction, cooperative haptics, medical robotics, and surgical simulation.

  • Alberto Salleo

    Alberto Salleo

    Hong Seh and Vivian W. M. Lim Professor, Professor of Photon Science, and Senior Fellow at the Precourt Institute for Energy

    Current Research and Scholarly InterestsNovel materials and processing techniques for large-area and flexible electronic/photonic devices. Polymeric materials for electronics, bioelectronics, and biosensors. Electrochemical devices for neuromorphic computing. Defects and structure/property studies of polymeric semiconductors, nano-structured and amorphous materials in thin films. Advanced characterization techniques for soft matter.

  • Joshua Salomon

    Joshua Salomon

    Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies

    BioJoshua Salomon is a Professor of Health Policy, a core faculty member in the Center for Health Policy, and Senior Fellow at the Freeman Spogli Institute for International Studies. His research focuses on public health policy and priority-setting, within three main substantive areas: (1) modeling patterns and trends in major causes of global mortality and disease burden; (2) evaluation of health interventions and policies; and (3) measurement and valuation of health outcomes.

    Dr. Salomon is an investigator on projects funded by the Centers for Disease Control and Prevention, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost effectiveness of new health technologies.

    He is Director of the Prevention Policy Modeling Lab, which is a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Prior to joining the Stanford faculty, Dr. Salomon was Professor of Global Health at Harvard T.H. Chan School of Public Health.

    For more information on the Prevention Policy Modeling Lab visit ppml.stanford.edu.

  • Julia Salzman

    Julia Salzman

    Associate Professor of Biomedical Data Science, of Biochemistry and, by courtesy, of Statistics and of Biology

    Current Research and Scholarly Interestsstatistical computational biology focusing on splicing, cancer and microbes

  • Jacinda Sampson

    Jacinda Sampson

    Clinical Professor, Adult Neurology

    BioDr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.

  • Niyatee Samudra, MD

    Niyatee Samudra, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Samudra is a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She is one of a small number of neurologists nationwide who is board-certified and fellowship-trained in epilepsy as well as in behavioral neurology and neuropsychiatry.

    Dr. Samudra leads a clinic at Stanford for the treatment of older adults with epilepsy. In addition, she has clinical interests in the treatment of atypical Parkinsonism and in women’s brain health across the lifespan. She co-leads the CurePSP Center of Care and is a member of the Menopause Collaborative of Practice at Stanford. Her varied research interests include clinical trials in neurodegenerative disease and in epilepsy; improving treatment for older adults with epilepsy; understanding the cognitive and neuropsychiatric consequences of epilepsy; and treatment of neuropsychiatric symptoms in neurodegenerative disorders.

    Prior to coming to Stanford, Dr. Samudra was a fellow in behavioral neurology and neuropsychiatry at the University of California, San Francisco, as well as in epilepsy and clinical neurophysiology at Vanderbilt University Medical Center. She completed her undergraduate degree at MIT and obtained her medical degree and neurology residency training at the University of Texas Southwestern Medical Center.

    Dr. Samudra has published in the Journal of Alzheimer’s Disease; Current Neurology and Neuroscience Reports; Journal of the Neurological Sciences; Seizure; and Epilepsy and Behavior, among others. She is a member of the American Epilepsy Society and the American Academy of Neurology.

  • Juan G. Santiago

    Juan G. Santiago

    Charles Lee Powell Foundation Professor

    Current Research and Scholarly Interestshttp://microfluidics.stanford.edu/Projects/Projects.html

  • Serena Sanulli

    Serena Sanulli

    Assistant Professor of Genetics

    Current Research and Scholarly InterestsWe study the organizing principles of the genome and how these principles regulate cell identity and developmental switches. We combine Biochemistry and Biophysical methods such as NMR and Hydrogen-Deuterium Exchange-MS with Cell Biology, and Genetics to explore genome organization across length and time scales and understand how cells leverage the diverse biophysical properties of chromatin to regulate genome function.

  • Kavita Sarin, MD, PhD

    Kavita Sarin, MD, PhD

    Professor of Dermatology

    Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.

  • Thea Sarino

    Thea Sarino

    Human Resource Administrator, Office of Technology Licensing (OTL)

    BioThea is responsible for assisting the Office of Technology Licensing team with any HR/Administrative related tasks.

  • Peter Sarnow

    Peter Sarnow

    Burt and Marion Avery Professor of Immunology

    Current Research and Scholarly InterestsOur laboratory studies virus-host interactions with an emphasis microRNA-mediated gene regulation and on translational control. The mechanism by which a liver-specific microRNA regulates hepatitis C virus genome replication is under intense scrutiny. In addition, the mechanism of internal ribosome entry in certain cellular and viral mRNAs and its biological role in growth and development is being investigated.

  • Clea Sarnquist, DrPH, MPH

    Clea Sarnquist, DrPH, MPH

    Clinical Professor, Pediatrics - Infectious Diseases
    Clinical Professor (By courtesy), Epidemiology and Population Health

    BioDr. Sarnquist focuses on applied teaching and research on the development, implementation and evaluation of interventions to decrease gender-based violence, improve mental health, and prevent HIV infection, especially among adolescents and children. She is particularly interested in rights-based approaches that tackle the complex interplay of factors that lead to poor health for many children and families. All of her work is applied, with direct links health practice and policy, and usually performed in conjunction with non-governmental organization and government partners. She works both globally and in the U.S., with a focus on sub-Saharan Africa. She is also a medical educator, directing the scholarly concentrations program of the pediatric residency at Stanford, co-directing the global health concentration for residents, and teaching graduate and undergraduate courses in global health with a focus on children and women’s health.

  • Ansuman Satpathy, MD, PhD

    Ansuman Satpathy, MD, PhD

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.

  • Elizabeth Sattely

    Elizabeth Sattely

    Associate Professor of Chemical Engineering

    BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.

  • Nazish Sayed MD, PhD

    Nazish Sayed MD, PhD

    Associate Professor (Research) of Surgery (Vascular Surgery)

    Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.

    Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology.

  • Nathaniel Scharping

    Nathaniel Scharping

    Casual - Non-Exempt, Office of Technology Licensing (OTL)
    Staff, Stanford Office of Technology Licensing

    BioNate is a science writer and editor from Tacoma, Washington, with almost a decade of experience covering health, medicine, the environment, and technology. He's interviewed Nobel-prize-winning scientists and reported from labs and field sites to show readers how science happens and why it matters.

  • Alan F. Schatzberg

    Alan F. Schatzberg

    Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.

  • Londa Schiebinger

    Londa Schiebinger

    John L. Hinds Professor of the History of Science

    BioLonda Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.

    Professor Schiebinger received her Ph.D. from Harvard University in 1984 and is a leading international authority on gender in science and technology. Over the past thirty years, Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.

    Londa Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the findings at the United Nations in New York, February 2011 with an update spring 2014. In 2022, she prepared the background paper for the United Nations 67th session of the Commission on the Status of Women’s priority theme, Innovation and Technological Change, and Education in the Digital Age for Achieving Gender Equality and The Empowerment of all Women and Girls. Since 2023, Gendered Innovations has been a member of the UNFPA Equity 2030 Alliance.

    In 2011-2014, Schiebinger entered into major collaborations with the European Commission and the U.S. National Science Foundation to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the U.S., Europe, Canada, and Asia, and was presented at the European Parliament, July 2013 as Gendered Innovations: How Gender Analysis Contributes to Research. In 2018-2020, Schiebinger directed the European Commission Expert Group to produce Gendered Innovations 2: How Inclusive Analysis Contributes to Research and Innovation. Institutes for Gendered Innovations research opened in Soeul, South Korea, in 2015 and in Tokyo, Japan, in 2022.

    Schiebinger’s work has been featured in Science: A Framework for Sex, Gender, and Diversity Analysis in Research: Funding Agencies Have Ample Room to Improve Their Policies (2022); Nature: Sex and Gender Analysis Improves Science and Engineering (2019); Nature: Design AI so that it's Fair (2018); Nature: Accounting for Sex and Gender Makes for Better Science (2020).

    Her work in the eighteenth century investigates the circulation of knowledge in the Atlantic World. Her Secret Cures of Slaves: People, Plants, and Medicine in the Eighteenth-Century Atlantic World reconceptualizes research in four areas: first and foremost knowledge of African contributions to early modern science; the historiography of race in science; the history of human experimentation; and the role of science in the eighteenth-century Atlantic world. Her prize-winning Plants and Empire: Colonial Bioprospecting in the Atlantic World investigates women's indigenous knowledge of abortifacients and why this knowledge did not travel.

    Londa Schiebinger has been the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and John Simon Guggenheim Fellowship. She was awarded an honorary doctorate from the Vrije Universiteit Brussel, Belgium (2013), the Faculty of Science, Lund University, Sweden (2017), and the University of Valencia, Spain (2018); the Berlin Falling Walls Breakthrough Winner in Science & Innovation Management (2022). Her work has been translated into numerous languages. In 2022/23, she served as an advisor to the Berlin University Alliance.

  • Alain Schläpfer

    Alain Schläpfer

    Social Science Research Scholar

    BioAlain Schläpfer is a Social Science Research Scholar at the Center on Democracy, Development and the Rule of Law, and a Lecturer in the Ford Dorsey Master's in International Policy. His research examines the evolution of cooperation among individuals and groups, with a particular emphasis on the role of reputational concerns. He also investigates the formation of preferences and of cultural norms, as well as their effects on behavior and long term outcomes. Alain's research has been published in journals in political science, economics and biology, and makes use of formal modelling, causal identification and computer simulations. Originally from Switzerland, Alain received his PhD from Universitat Pompeu Fabra in Barcelona, Spain.

  • Ludwig Schmidt

    Ludwig Schmidt

    Assistant Professor of Computer Science

    BioLudwig Schmidt is an assistant professor at Stanford University in the Computer Science Department and Stanford Data Science. Ludwig’s research interests revolve around the empirical foundations of machine learning, often with a focus on datasets, reliable generalization, multimodality, and language models. Recently, Ludwig’s research group contributed to open source machine learning by creating OpenCLIP, DCLM, and the LAION-5B dataset. Ludwig completed his PhD at MIT and was a postdoc at UC Berkeley. Ludwig’s research received a new horizons award at EAAMO, best paper awards at ICML & NeurIPS, a best paper finalist at CVPR, and the Sprowls dissertation award from MIT.

  • David Schneider

    David Schneider

    Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsWe study innate immunity and microbial pathogenesis. We have been studying models for a variety of bacterial infections including: Listeria, Mycobacteria, Salmonella and Streptococcus as well as some fungi, malaria and viruses. Our current focus is to determine how we recover from infections.

  • Mark J. Schnitzer

    Mark J. Schnitzer

    Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor of Biology, of Applied Physics and of Neurosurgery

    Current Research and Scholarly InterestsThe goal of our research is to advance experimental paradigms for understanding normal cognitive and disease processes at the level of neural circuits, with emphasis on learning and memory processes. To advance these paradigms, we invent optical brain imaging techniques, several of which have been widely adopted. Our neuroscience studies combine these imaging innovations with behavioral, electrophysiological, optogenetic and computational methods, enabling a holistic approach to brain science.

  • Robert W Schoenlein

    Robert W Schoenlein

    Research Technical Manager, SLAC National Accelerator Laboratory

    Current Role at StanfordDeputy Director for Science at the Linac Coherent Light Source
    Principal Investigator in the Stanford PULSE Institute at SLAC

  • Kristin Schreiber

    Kristin Schreiber

    Professor of Anesthesiology, Perioperative & Pain Medicine (Regional Anesthesia)

    BioDr. Kristin Schreiber is a Professor and Regional Anesthesiologist whose clinical work involves caring for surgical patients in the perioperative period, and whose research work is centered around predicting and preventing Chronic Postsurgical Pain (CPSP). Her PhD in Neuroscience investigated mechanisms of spinal plasticity in the development of chronic pain states, and her translational clinical research program aims to understand which patient are at risk to develop CPSP, why, and how to best prevent it in different individuals. She employs the careful preoperative pain phenotyping, investigating factors that underlie variability in postsurgical trajectories, and testing both pharmacologic and behavioral interventions to reduce postsurgical pain. Her quantitative sensory testing lab-based studies investigate difference in pain processing, in the absence and presence of modulators of pain including regional anesthesia, placebo, distraction, and music. She has enjoyed continuous external funding from the NIH since 2015, and has held administrative roles including associate VC of Research, and VC of Faculty Development, and PI of a translational pain research training grant at Harvard Medical School. She is a handling editor at Anesthesiology, and Pain Medicine, and currently serves as the Chief of Regional Anesthesia in the Department of Anesthesiology, Perioperative, and Pain Medicine.

  • Dustin Schroeder

    Dustin Schroeder

    Associate Professor of Geophysics, of Electrical Engineering and Senior Fellow at the Woods Institute for the Environment

    BioMy research focuses on advancing the scientific and technical foundations of geophysical ice penetrating radar and its use in observing and understanding the interaction of ice and water in the solar system. I am primarily interested in the subglacial and englacial conditions of rapidly changing ice sheets and their contribution to global sea level rise. However, a growing secondary focus of my work is the exploration of icy moons. I am also interested in the development and application of science-optimized geophysical radar systems. I consider myself a radio glaciologist and strive to approach problems from both an earth system science and a radar system engineering perspective. I am actively engaged with the flow of information through each step of the observational science process; from instrument and experiment design, through data processing and analysis, to modeling and inference. This allows me to draw from a multidisciplinary set of tools to test system-scale and process-level hypotheses. For me, this deliberate integration of science and engineering is the most powerful and satisfying way to approach questions in Earth and planetary science.

  • Shari Schuchmann

    Shari Schuchmann

    Senior Marketing Analyst, Office of Technology Licensing (OTL)
    Staff, Stanford Office of Technology Licensing

    BioPrior to joining Stanford Office of Technology Licensing, Shari worked in industries ranging from semiconductor equipment to early-stage venture capital. Shari focuses on business development and outreach for Stanford technologies in the physical sciences.

    Education
    M.B.A. (London Business School)
    M.S. Nuclear Engineering (Massachusetts Institute of Technology)
    B.S. Material Science and Engineering, B.S. Nuclear Engineering (Massachusetts Institute of Technology)

    Business Experience
    Playground Destination Properties, An Intrawest Company (Western Region Business Unit Manager)
    Interregnum, PLC (Principal, Investments)
    Novellus Systems acquired by Lam Research (Sr Process Engineer, Dielectric Applications Lab Manager)
    TORAY Industries, Inc (Visiting Researcher)

  • Birgitt Schuele

    Birgitt Schuele

    Associate Professor (Research) of Pathology and, by courtesy, of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsThe Schuele lab focuses on neurogenetics, human stem cell modeling, and gene therapy approaches to uncover disease mechanisms and pathways involved in neurodegeneration in Parkinson's, Alzheimer's disease and related disorders.

  • Kevin Schulman

    Kevin Schulman

    Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business

    BioDr. Schulman is a Professor of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He serves as an Associate Chair of the Department of Medicine. He is the Faculty Director of Stanford’s new applied master degree program, the Master of Science in Clinical Informatics Management program. He also serves as Deputy Director of the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and has an appointment in the Department of Health Policy (by courtesy).

    Dr. Schulman is a health economist/health services researcher working at the intersection of business, medicine and technology. With over 500 publications, he has had a broad impact on several areas of health policy (Scopus h-index=83). His research has appeared in the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the editor-in-chief of Health Management, Policy and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Service Research (HSR).

    He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program. He is an elected member of ASCI and AAP.

  • Elizabeth Schumann

    Elizabeth Schumann

    Billie Bennett Achilles Director of Keyboard Programs and Assistant Professor (Teaching) of Music

    Current Research and Scholarly InterestsAs a concert pianist, I deeply value the rich traditions of classical music. My passion lies in blending this artistry with scientific insights from neuroscience to biomechanics. This isn't solely about music; it's about applying lessons about optimal practice and peak performance to life's broader canvas. Through my research, I strive to evolve musical training, paving the way for the next generation of dedicated and resilient performers.

  • Molly Schumer

    Molly Schumer

    Associate Professor of Biology

    BioMolly Schumer is an Assistant Professor in Biology. She is interested in genetics and evolutionary biology. After receiving her PhD at Princeton, she did her postdoctoral work at Columbia and was a Junior Fellow in the Harvard Society of Fellows and Hanna H. Gray Fellow at Harvard Medical School. Current research in the lab centers on understanding the genetic mechanisms of evolution, with a focus on natural populations.

  • Daniel Schwartz

    Daniel Schwartz

    Dean of the Graduate School of Education and the Nomellini & Olivier Professor of Educational Technology

    Current Research and Scholarly InterestsInstructional methods, transfer of learning and assessment, mathematical development, teachable agents, cognition, and cognitive neuroscience.

  • Neil Schwartz, MD, PhD

    Neil Schwartz, MD, PhD

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsMy clinical interests involve inpatient and outpatient care of patients with neurovascular diseases, mostly ischemic and hemorrhagic stroke. I have a particular interest in cervical artery dissection, non-atherosclerotic vasculopathies, and stroke in the young.

  • Matthew P. Scott

    Matthew P. Scott

    Professor of Developmental Biology, Emeritus

    Current Research and Scholarly InterestsOur research has been focused on the genetic regulation of animal development and its relation to birth defects, cancer, and neurodegeneration. We studied mechanisms and functions of Hedgehog (Hh) signaling, which controls cell fates and growth, in the context of normal development and brain cancer. We studied a neurodegenerative disease, Niemann-Pick C syndrome, that affects intracellular organelle movements and sterol homeostasis. Due to Dr. Scott's new job, the lab is no longer active.

  • Vittorio Sebastiano

    Vittorio Sebastiano

    Associate Professor (Research) of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)

    Current Research and Scholarly InterestsThe thread of Ariadne that connects germ cells, preimplatation development and pluripotent stem cells is the focus of my research, with a specific interest in human development. My long-term goals are: 1. Understanding the biology of germ cells and and their ability to sustain early preimplantation development; 2. Understanding the mechanisms that regulate very early cell fate decisions in human embryos; 3. Understanding the biology of derivation and maintenance of Pluripotent Stem Cells